Selection of an attenuated Coxsackievirus B3 variant, using a monoclonal antibody reactive to myocyte antigen.
about
c-FLIP-Short reduces type I interferon production and increases viremia with coxsackievirus B3Coxsackievirus B3 inhibits antigen presentation in vivo, exerting a profound and selective effect on the MHC class I pathway.Genomic determinants of cardiovirulence in coxsackievirus B3 clinical isolates: localization to the 5' nontranslated region.Roles of tumor necrosis factor alpha (TNF-alpha) and the p55 TNF receptor in CD1d induction and coxsackievirus B3-induced myocarditis.Tumor necrosis factor-alpha promotes myocarditis in female mice infected with coxsackievirus B3 through upregulation of CD1d on hematopoietic cells.Cross-talk between cd1d-restricted nkt cells and γδ cells in t regulatory cell response.Sex chromosome complement contributes to sex differences in coxsackievirus B3 but not influenza A virus pathogenesis.Alterations in major histocompatibility complex association of myocarditis induced by coxsackievirus B3 mutants selected with monoclonal antibodies to group A streptococciModulation of cytokine expression by CD4+ T cells during coxsackievirus B3 infections of BALB/c mice initiated by cells expressing the gamma delta + T-cell receptor.A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3.IL-21R expression on CD8+ T cells promotes CD8+ T cell activation in coxsackievirus B3 induced myocarditisWild-type coxsackievirus infection dramatically alters the abundance, heterogeneity, and immunostimulatory capacity of conventional dendritic cells in vivoCoxsackievirus can exploit LC3 in both autophagy-dependent and -independent manners in vivo.Antibody-resistant mutants of Borrelia burgdorferi: in vitro selection and characterizationDeletions within the 5'UTR of coxsackievirus B3: consequences for virus translation and replication.Enumeration and functional evaluation of virus-specific CD4+ and CD8+ T cells in lymphoid and peripheral sites of coxsackievirus B3 infectionSlam haplotype 2 promotes NKT but suppresses Vγ4+ T-cell activation in coxsackievirus B3 infection leading to increased liver damage but reduced myocarditisCoxsackievirus B3 infects the bone marrow and diminishes the restorative capacity of erythroid and lymphoid progenitors.ERβ and ERα Differentially Regulate NKT and Vγ4(+) T-cell Activation and T-regulatory Cell Response in Coxsackievirus B3 Infected MiceT cells expressing the gamma delta T-cell receptor potentiate coxsackievirus B3-induced myocarditisAn attenuated variant of Coxsackievirus B3 preferentially induces immunoregulatory T cells in vivoCoxsackievirus B3 induction of NFAT: requirement for myocarditis susceptibilityIn vivo ablation of type I interferon receptor from cardiomyocytes delays coxsackieviral clearance and accelerates myocardial disease.Selection of Mycoplasma hominis PG21 deletion mutants by cultivation in the presence of monoclonal antibody 552.Augmentation of pathogenesis of coxsackievirus B3 infections in mice by exogenous administration of interleukin-1 and interleukin-2.Tissue-specific deletion of the coxsackievirus and adenovirus receptor protects mice from virus-induced pancreatitis and myocarditis.Coxsackievirus infection induces autophagy-like vesicles and megaphagosomes in pancreatic acinar cells in vivo.γδ T lymphocytes kill T regulatory cells through CD1d.Depletion of gammadelta+ T cells increases CD4+ FoxP3 (T regulatory) cell response in coxsackievirus B3-induced myocarditis.
P2860
Q27335025-3A21DB79-B6B3-4904-953E-E03B46F525C3Q33510911-4B9E7E24-4869-4AD2-A743-71949CCBE7F5Q33804871-0C103157-31DF-4C6B-9B65-E1460054B85CQ33833868-F13FABB1-1E5A-4D76-92D6-DBBBAD5B9A59Q33905161-09071060-A3E5-44A2-8464-633B86C93447Q34550454-A83F90B3-200B-4A79-9E63-B74FAED906D5Q35184087-A1B5BF3A-B41B-4DCD-9FFA-D09C6CA5AA35Q35485479-672A6806-D1BD-4FDD-869F-572DAFFAC206Q35860309-5613F2C5-84D4-446A-8876-A986EC32B9A6Q35872223-F6BD45B6-D449-4CED-8CF9-AE34FB742155Q35965698-0DD2C547-B692-4159-AA83-99A824B12E37Q35981115-DC346052-FE88-43C4-8188-66E065C28F20Q36111700-5795858D-5941-4ABB-B0A9-F430B7FE693FQ36231714-222094D4-0DC8-436D-A679-7AEA6180BFA3Q36359523-069DC507-F6F9-4CD1-A084-BEFF801B8413Q36540118-63395774-EBCF-4CF2-B8D0-5FF5EB47BE14Q36582861-D7FFD952-C2A4-40A7-88A3-7A19BC83B23AQ36607055-95ADA64E-E824-42E3-8DCE-A61108D7F1DDQ36611453-AA75241C-651B-4517-BA4F-C35D5C7E5F70Q36685183-44138E53-9241-4F2D-8E47-6DA1BB8C7A0FQ36820749-1FEBC844-9223-4FB0-BF2E-DE0BB6D13149Q36990137-3095CB52-587D-4788-8F9A-0FEF382C2CA4Q37713958-6CBF9E90-5BEC-42FD-902F-D7AC01E77EB1Q39822848-E6CEB2C3-78DF-41ED-9F44-B53DE4BF899CQ40037798-7504ABF9-D193-459C-9336-B7C0D61B7090Q41834966-FD51C5E3-7956-4EE9-AC81-CAB89D924B7CQ42375433-EED0E67D-6E3C-4796-8C82-6E8F7BF96E23Q42836687-1BF74DFE-7823-4F07-A65A-EEB7BFC8A3D9Q44168970-75FA9024-0CE3-4021-9537-A2F0D124AA15
P2860
Selection of an attenuated Coxsackievirus B3 variant, using a monoclonal antibody reactive to myocyte antigen.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Selection of an attenuated Cox ...... y reactive to myocyte antigen.
@ast
Selection of an attenuated Cox ...... y reactive to myocyte antigen.
@en
type
label
Selection of an attenuated Cox ...... y reactive to myocyte antigen.
@ast
Selection of an attenuated Cox ...... y reactive to myocyte antigen.
@en
prefLabel
Selection of an attenuated Cox ...... y reactive to myocyte antigen.
@ast
Selection of an attenuated Cox ...... y reactive to myocyte antigen.
@en
P2093
P2860
P1433
P1476
Selection of an attenuated Cox ...... y reactive to myocyte antigen.
@en
P2093
N Van Houten
P E Bouchard
P2860
P304
P407
P577
1991-03-01T00:00:00Z